Interim Phase 2 Data Suggest Activity of Panitumumab with Chemotherapy in First-Line Treatment of Metastatic Colorectal Cancer Read more about Interim Phase 2 Data Suggest Activity of Panitumumab with Chemotherapy in First-Line Treatment of Metastatic Colorectal Cancer
FDA Approves New and Easy Way to Take ENBREL; Benefits of ENBREL Delivered in Convenient Once-Weekly 50 mg/mL Prefilled Syringe Read more about FDA Approves New and Easy Way to Take ENBREL; Benefits of ENBREL Delivered in Convenient Once-Weekly 50 mg/mL Prefilled Syringe
Amgen Investigational Therapy for Bone Loss, AMG 162, Increased Bone Mineral Density with Twice Yearly Injection Read more about Amgen Investigational Therapy for Bone Loss, AMG 162, Increased Bone Mineral Density with Twice Yearly Injection
Amgen Announces Webcast of Third Quarter Financial Results Read more about Amgen Announces Webcast of Third Quarter Financial Results
Amgen Names Rolf Hoffmann Senior Vice President, European Operations Read more about Amgen Names Rolf Hoffmann Senior Vice President, European Operations
Court Rules in Amgen's Favor in TKT Litigation; Affirms Validity of EPO Patents Read more about Court Rules in Amgen's Favor in TKT Litigation; Affirms Validity of EPO Patents
New Two-Year Data Show That Most Rheumatoid Arthritis Patients Treated with ENBREL Plus Methotrexate Had No Progression of Joint Damage Read more about New Two-Year Data Show That Most Rheumatoid Arthritis Patients Treated with ENBREL Plus Methotrexate Had No Progression of Joint Damage
Amgen's Third Quarter 2004 Adjusted Earnings Per Share Increased 21 Percent to 64 Cents Read more about Amgen's Third Quarter 2004 Adjusted Earnings Per Share Increased 21 Percent to 64 Cents
FDA Approves ENBREL to Induce Major Clinical Response in Patients With Rheumatoid Arthritis; Additional Data Demonstrates Increased Levels of Sustained Disease Control Read more about FDA Approves ENBREL to Induce Major Clinical Response in Patients With Rheumatoid Arthritis; Additional Data Demonstrates Increased Levels of Sustained Disease Control
Amgen Announces Plans to Webcast Selected Management Presentations Read more about Amgen Announces Plans to Webcast Selected Management Presentations
